< Return to previous page

Michael Severino

Tessera Therapeutics
Chief Executive Officer

Michael Severino has served as Chief Executive Officer of Tessera Therapeutics and CEO-Partner of Flagship Pioneering since June 2022. Mike has more than two decades of biopharmaceutical leadership experience and has made significant contributions to the research, development, registration, and commercialization of more than a dozen approved therapies. Mike joined from AbbVie, where he was Vice Chairman and President responsible for research and development and the corporate strategy office. Mike earned his B.S. in biochemistry from the University of Maryland, College Park, where he graduated summa cum laude.

Read Full Bio

Michael Severino

Tessera Therapeutics
Chief Executive Officer
mike severino